Image

Non-invasive Detection of Volatile Metabolites in Parkinson's Disease

Detecting Parkinson's disease through breath analysis, no invasive tests needed.

Recruiting
18-90 years
All
Phase N/A

Parkinson's disease (PD) is a condition that affects the brain and is the second most common neurodegenerative disorder. Currently, there is no test to find PD early. This study aims to create a simple, non-invasive breath test to detect early PD. Breath contains tiny molecules that can help show if someone has a disease. By studying these molecules and changes in gut bacteria, researchers hope to find PD before symptoms appear. This could help start treatments earlier and improve patients' lives.

The study will look at volatile organic compounds (VOCs), small molecules in breath that can show how the body is working. The study will include 120 participants: 50 PD patients, 50 healthy controls, and 20 newly diagnosed PD patients not taking medication. They will collect samples like breath, stool, and blood to study.

  • The study needs PD patients and healthy volunteers aged 18 to 90.
  • Participants should not have taken antibiotics or probiotics in the last 4 weeks.
  • No formal diagnosis of gut-related issues (dysbiosis) is allowed.
Study details
    Parkinson Disease

NCT06453226

Imperial College London

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.